Stay updated on Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Locations section expanded to include numerous new sites across the United States and internationally, broadening the geographic coverage of the trial.
    Difference
    3%
    Check dated 2025-12-23T09:21:53.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    A minor version label update is shown: Revision: v3.3.2 is now displayed, replacing Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:41:35.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    PubMed publications section wording updated to 'automatically filled in from PubMed'. Page revision tag updated to Revision: v3.3.1.
    Difference
    0.3%
    Check dated 2025-11-24T14:50:45.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Two new study sites in Taiwan were added: Tainan, Taiwan, 704 and Tainan, Taiwan, 71004. The previous Tainan City entries for these locations were removed.
    Difference
    0.2%
    Check dated 2025-11-17T07:14:10.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Visual layout tweaks (spacing and header styling) appear in the screenshots, with no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T01:23:27.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Updated page to v3.2.0 with a new government-operating-status notice; removed the resource for Differentiated thyroid carcinoma from the Genetic and Rare Diseases Information Center.
    Difference
    3%
    Check dated 2025-10-05T10:36:13.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.